We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Medicine

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What is Pazopanib?

Mary McMahon
By
Updated: May 17, 2024
Views: 4,259
Share

Pazopanib is a chemotherapeutic agent a doctor may prescribe as part of the treatment plan for renal cell carcinoma and certain other cancers. The patient may take this drug alone or with other medications, to attack the cancer from multiple angles. It is available by prescription only and comes in the form of tablets the patient must take regularly to keep levels of the drug in the body stable. During treatment, the patient must attend regular follow-up appointments to see if the cancer is responding and check for dangerous side effects.

This drug inhibits the activity of tyrosine kinase, an enzyme involved in the regulation of activities inside cells. Patients on pazopanib have problems with uncontrolled cell growth and the development of new blood vessels to supply cancerous tumors. The drug inhibits cell replication and limits opportunities for angiogenesis, cutting off the supply of blood to a cancer while preventing it from growing any larger. Adding a second drug to the regimen may make it more effective by limiting other cellular activities in the cancer.

Patients on pazopanib can experience a number of side effects because the drug also harms healthy cells. Hair loss, stomach discomfort, rashes, and swelling of the extremities may occur. Some patients develop fatigue, sensitivity to cold, and loss of appetite. More seriously, pazopanib can sometimes cause internal bleeding and liver damage. The patient should discuss side effects with a doctor to determine if they are signs of an adverse reaction to the drug and get more information about how to manage them. It may be possible to adjust the dosage or take another medication to control unpleasant side effects.

Studies suggest pazopanib can cause harm in pregnant women. Pregnant women with cancer should discuss their treatment options with an oncologist and obstetrician. Leaving the cancer untreated can pose more risks than taking potentially teratogenic medications that might harm the fetus. It may be possible to limit damage to the fetus or to pursue options like banking eggs in the hopes of future pregnancies, possibly through surrogacy, after successful treatment of the cancer.

Chemotherapy regimens can last for varying lengths of time. They are often stressful and patients can benefit from joining a support group or receiving assistance through a community network for cancer patients. Support can vary from offering rides to patients so they don't have to drive to the doctor to counseling sessions to help people cope with a cancer diagnosis.

Share
WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a WiseGeek researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Editors' Picks

Discussion Comments
Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
Share
https://www.wisegeek.net/what-is-pazopanib.htm
Copy this link
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.